Compare ESTA & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | ADNT |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2018 | 2016 |
| Metric | ESTA | ADNT |
|---|---|---|
| Price | $69.91 | $21.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $86.86 | $25.41 |
| AVG Volume (30 Days) | 322.1K | ★ 621.2K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $61,208,000.00 | ★ $17,439,000,000.00 |
| Revenue This Year | $28.05 | $2.71 |
| Revenue Next Year | $26.21 | $2.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 76.49 | 7.56 |
| 52 Week Low | $32.25 | $11.89 |
| 52 Week High | $83.31 | $27.32 |
| Indicator | ESTA | ADNT |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 50.85 |
| Support Level | $68.75 | $18.69 |
| Resistance Level | $73.72 | $21.76 |
| Average True Range (ATR) | 3.36 | 0.82 |
| MACD | 0.55 | 0.02 |
| Stochastic Oscillator | 79.31 | 41.05 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.